POLYMERIZED MIDGE ALLERGEN IMMUNOTHERAPY (PMAIT) - CLINICAL REDUCTIONIN EARLY AND LATE-PHASE REACTIVITY AND PREVENTION OF RHINITIS AND ASTHMA MORBIDITY
R. Knoll et al., POLYMERIZED MIDGE ALLERGEN IMMUNOTHERAPY (PMAIT) - CLINICAL REDUCTIONIN EARLY AND LATE-PHASE REACTIVITY AND PREVENTION OF RHINITIS AND ASTHMA MORBIDITY, Journal of allergy and clinical immunology, 93(1), 1994, pp. 251-251